Novel targeted therapy for triple-negative breast cancer
Researchers from Hong Kong Baptist University (HKBU) have developed a novel targeted therapy for triple-negative breast cancer (TNBC) that uses a specially-designed nano-carrier to deliver the Chinese medicine compound gambogic acid (GA). The invention enhances the anti-cancer effect of GA and reduces its damage to off-target organs, and it could become a more effective therapeutic option for TNBC.
